GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

Blockchain is poised to redefine pharmaceutical validation, offering unparalleled improvements in data integrity, compliance, ...

We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?